RP-HPLC method development and validation for estimation of Voglibose in bulk and tablet dosage forms

Mallikarjuna Rao N. (1) , Konda Ravi Kumar (2) , Bagyalakshmi J. (3) , Ravi T.K. (4) , Ramakotaiah Mogili (5)
(1) Department of Pharmaceutical Analysis, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, New Siddapudur, Coimbatore, Tamilnadu, India, India ,
(2) Department of Pharmaceutical Chemistry, Siddhartha Institute of Pharmaceutical Sciences, JonnalaGadda, Narasaraopet, Guntur – 522601, Andhra Pradesh, India, India ,
(3) Department of Pharmaceutical Analysis, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, New Siddapudur, Coimbatore, Tamilnadu, India, India ,
(4) Department of Pharmaceutical Analysis, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, New Siddapudur, Coimbatore, Tamilnadu, India, India ,
(5) Department of Pharmaceutics, Don Bosco College of Pharmacy, Pulladigunta, Guntur (Dt) – 522 517 Andhra Pradesh, India, India

Abstract

A simple, sensitive, precise and specific reverse phase high performance liquid chromatographic method was developed and validated for the determination of voglibose in bulk and tablet dosage forms. It was found that the excipient in the tablet dosage forms does not interfere in the quantification of active drug by proposed method. The HPLC separation was carried out by reverse phase chromatography on RP-18e, Hibar RT column (250×4.6mm) with a mobile phase composed of 0.025M potassium dihydrogen phosphate pH 2.5 : acetonitrile: methanol (40:55:5) in isocratic mode at a flow rate of 1ml/min. As voglibose cannot be directly detected with high sensitivity, it was derivatized with Taurine and sodium periodate. The detection was monitored at 282nm. The calibration curve for voglibose was linear from 100 to 500ng/ml. The interday and intraday precision was found to be within limits. The proposed method has adequate sensitivity, reproducibility and specificity for the determination of voglibose in bulk and its tablet dosage forms. LOD and LOQ for voglibose were found to be 30ng/ml and 100ng/ml. Accuracy (recoveries: 99.8-101.2%) and reproducibility were found to satisfactory.

Full text article

Generated from XML file

Authors

Mallikarjuna Rao N.
mallimpharmmba@gmail.com (Primary Contact)
Konda Ravi Kumar
Bagyalakshmi J.
Ravi T.K.
Ramakotaiah Mogili
Mallikarjuna Rao N., Konda Ravi Kumar, Bagyalakshmi J., Ravi T.K., & Ramakotaiah Mogili. (2010). RP-HPLC method development and validation for estimation of Voglibose in bulk and tablet dosage forms. International Journal of Research in Pharmaceutical Sciences, 1(2), 190–194. Retrieved from https://ijrps.com/home/article/view/2887

Article Details

Most read articles by the same author(s)

No Related Submission Found